COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Coronavirus Guidance for NIH Applicants and Grantees:

Dr. Deborah Hodge

Dr. Deborah Hodge

Scientific Review Officer


Division of Physiological and Pathological Sciences DPPS
Immunology IMM
Study Section:
Hypersensitivity, Autoimmune and Immune-mediated Diseases HAI

Dr. Deborah Hodge is the Scientific Review Officer for CSR’s Hypersensitivity, Autoimmune and Immune-mediated Diseases study section.

Dr. Hodge came to this position after an extended tenure in research at the Laboratory of Experimental Immunology, National Cancer Institute, where she studied regulation of immune genes with a focus on transcriptional and posttranscriptional regulation of interferon gamma expression in natural killer cells. Dr. Hodge received a Ph.D. in biochemistry from West Virginia University, where she studied gene regulation of glucose-6-phosphate dehydrogenase, an enzyme linked to intermediary metabolism.